Inhibiting gluconeogenesis prevents fatty acid-induced increases in endogenous glucose production

American Journal of Physiology - Endocrinology and Metabolism

Volumn 297, Issue 1, 2009, Pages

  Kehlenbrink, Sylvia ^a   Tonelli, Julia ^a   Koppaka, Sudha ^a   Chandramouli, Visvanathan ^b   Hawkins, Meredith ^a   Kishore, Preeti ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Diabetes mellitus; Free fatty acids; Hyperglycemia

Indexed keywords

ALCOHOL; FATTY ACID; GLUCOSE; INSULIN; LIPOSYN; SOMATOSTATIN;

ADULT; ARTICLE; FATTY ACID METABOLISM; FEMALE; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE LIVER LEVEL; HUMAN; HUMAN EXPERIMENT; HYPERGLYCEMIA; LIVER METABOLISM; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NORMAL HUMAN; PRIORITY JOURNAL;

ADULT; DOWN-REGULATION; EFFICIENCY; ETHANOL; FATTY ACIDS, NONESTERIFIED; FEMALE; GLUCONEOGENESIS; GLUCOSE; GLUCOSE CLAMP TECHNIQUE; HUMANS; LIVER; MALE; MIDDLE AGED; TIME FACTORS;

EID: 67650093470     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00001.2009     Document Type: Article

References (50)

1. Aiston S, Andersen B, Agius L. Glucose 6-phosphate regulates hepatic glycogenolysis through inactivation of phosphorylase. Diabetes 52: 1333-1339, 2003.
2. Antras-Ferry J, Le Bigot G, Robin P, Robin D, Forest C. Stimulation of phosphoenolpyruvate carboxykinase gene expression by fatty acids. Biochem Biophys Res Commun 203: 385-391, 1994.
3. Avogaro A, Valerio A, Miola M, Crepaldi C, Pavan P, Tiengo A, del Prato S. Ethanol impairs insulin-mediated glucose uptake by an indirect mechanism. J Clin Endocrinol Metab 81: 2285-2290, 1996.
4. Balent B, Goswami G, Goodloe G, Rogatsky E, Rauta O, Nezami R, Mints L, Angeletti RH, Stein DT. Acute elevation of NEFA causes hyperinsulinemia without effect on insulin secretion rate in healthy human subjects. Ann NY Acad Sci 967: 535-543, 2002.
5. Basu A, Basu R, Shah P, Vella A, Johnson CM, Jensen M, Nair KS, Schwenk WF, Rizza RA. Type 2 diabetes impairs splanchnic uptake of glucose but does not alter intestinal glucose absorption during enteral glucose feeding: additional evidence for a defect in hepatic glucokinase activity. Diabetes 50: 1351-1362, 2001.
6. Bell PM, Firth RG, Rizza RA. Effects of hyperglycemia on glucose production and utilization in humans. Measurement with [23H]-, [33H]-, and [614C]glucose. Diabetes 35: 642-648, 1986.
7. Best JD, Kahn SE, Ader M, Watanabe RM, Ni TC, Bergman RN. Role of glucose effectiveness in the determination of glucose tolerance. Diabetes Care 19: 1018-1030, 1996.
8. Boden G. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 46: 3-10, 1997.
9. Boden G, Chen X, Capulong E, Mozzoli M. Effects of free fatty acids on gluconeogenesis and autoregulation of glucose production in type 2 diabetes. Diabetes 50: 810-816, 2001.
10. Boden G, Chen X, Stein TP. Gluconeogenesis in moderately and severely hyperglycemic patients with type 2 diabetes mellitus. Am J Physiol Endocrinol Metab 280: E23-E30, 2001.
11. Bogardus C, Lillioja S, Howard B, Reaven G, Mott D. Relationship between insulin secretion, insulin action, and fasting plasma glucose concentration in nondiabetic and T2DM subjects. J Clin Invest 74: 1238-1246, 1984.
12. Caro JF, Triester S, Patel VK, Tapscott EB, Frazier NL, Dohm GL. Liver glucokinase: decreased activity in patients with type II diabetes. Horm Metab Res 27: 19-22, 1995.
13. Chen X, Iqbal N, Boden G. The effects of free fatty acids on gluconeogenesis and glycogenolysis in normal subjects. J Clin Invest 103: 365-372, 1999.
14. Chu CA, Sherck SM, Igawa K, Sindelar DK, Neal DW, Emshwiller M, Cherrington AD. Effects of free fatty acids on hepatic glycogenolysis and gluconeogenesis in conscious dogs. Am J Physiol Endocrinol Metab 282: E402-E411, 2002.
15. Clore JN, Stillman J, Sugerman H. Glucose-6-phosphatase flux in vitro is increased in type 2 diabetes. Diabetes 49: 969-974, 2000.
16. DeFronzo RA. Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes 37: 667-687, 1988.
17. DeFronzo RA, Ferrannini E, Hendler R, Felig P, Wahren J. Regulation of splanchnic and peripheral glucose uptake by insulin and hyperglycemia in man. Diabetes 32: 35-45, 1983.
18. Greenway CV, Lautt WW. Acute and chronic ethanol on hepatic oxygen ethanol and lactate metabolism in cats. Am J Physiol Gastrointest Liver Physiol 258: G411-G418, 1990.
19. Hawkins M, Gabriely I, Wozniak R, Reddy K, Rossetti L, Shamoon H. Glycemic control determines hepatic and peripheral glucose effectiveness in type 2 diabetic subjects. Diabetes 51: 2179-2189, 2002.
20. Hawkins M, Gabriely I, Wozniak R, Vilcu C, Shamoon H, Rossetti L. Fructose improves the ability of hyperglycemia per se to regulate glucose production in type 2 diabetes. Diabetes 51: 606-614, 2002.
21. Hawkins M, Tonelli J, Kishore P, Stein D, Ragucci E, Gitig A, Reddy K. Contribution of elevated free fatty acid levels to the lack of glucose effectiveness in type 2 diabetes. Diabetes 52: 2748-2758, 2003.
22. Jenssen T, Nurjhan N, Consoli A, Gerich JE. Failure of substrate-induced gluconeogenesis to increase overall glucose appearance in normal humans. Demonstration of hepatic autoregulation without a change in plasma glucose concentration. J Clin Invest 86: 489-497, 1990.
23. Kishore P, Tonelli J, Koppaka S, Fratila C, Bose A, Lee D, Reddy K, Hawkins M. Time-dependent effects of free fatty acids on glucose effectiveness in type 2 diabetes. Diabetes 55: 1761-1768, 2006.
24. Lam TK, Carpentier A, Lewis GF, van de Werve G, Fantus IG, Giacca A. Mechanisms of the free fatty acid-induced increase in hepatic glucose production. Am J Physiol Endocrinol Metab 284: E863-E873, 2003.
25. Lam TK, Van de Werve G, Giacca A. Free fatty acids increase basal hepatic glucose production and induce hepatic insulin resistance at different sites. Am J Physiol Endocrinol Metab 284: E281-E290, 2003.
26. Landau BR, Wahren J, Chandramouli V, Schumann WC, Ekberg K, Kalhan SC. Contributions of gluconeogenesis to glucose production in the fasted state. J Clin Invest 98: 378-385, 1996.
27. Liljenquist JE, Mueller GL, Cherrington AD, Perry JM, Rabinowitz D. Hyperglycemia per se (insulin and glucagon withdrawn) can inhibit hepatic glucose production in man. J Clin Endocrinol Metab 48: 171-175, 1979.
28. Long SD, Pekala PH. Regulation of GLUT4 gene expression by arachidonic acid. Evidence for multiple pathways, one of which requires oxidation to prostaglandin E2. J Biol Chem 271: 1138-1144, 1996.
29. Magnusson I, Rothman DL, Katz LD, Shulman RG, Shulman GI. Increased rate of gluconeogenesis in type II diabetes mellitus. A 13C nuclear magnetic resonance study. J Clin Invest 90: 1323-1327, 1992.
30. Massillon D, Barzilai N, Hawkins M, Prus-Wertheimer D, Rossetti L. Induction of hepatic glucose-6-phosphatase gene expression by lipid infusion. Diabetes 46: 153-157, 1997.
31. Mevorach M, Giacca A, Aharon Y, Hawkins M, Shamoon H, Rossetti L. Regulation of endogenous glucose production by glucose per se is impaired in type 2 diabetes mellitus. J Clin Invest 102: 744-753, 1998.
32. Mokuda O, Tanaka H, Hayashi T, Ooka H, Okazaki R, Sakamoto Y. Ethanol stimulates glycogenolysis and inhibits both glycogenesis via gluconeogenesis and from exogenous glucose in perfused rat liver. Ann Nutr Metab 48: 276-280, 2004.
33. Nagasaka S, Tokuyama K, Kusaka I, Hayashi H, Rokkaku K, Nakamura T, Kawakami A, Higashiyama M, Ishikawa S, Saito T. Endogenous glucose production and glucose effectiveness in type 2 diabetic subjects derived from stable-labeled minimal model approach. Diabetes 48: 1054-1060, 1990.
34. National Institute on Alcohol Abuse and Alcoholism. Recommended Council Guidelines on Ethyl Alcohol Administration in Human Experimentation (Online). http://www.niaaa.nih.gov/Resources/ResearchResources/job22.htm [October 2003].
35. Nolte L, Rincon A, Wahlstrom EO, Craig BW, Zierath JR, Wallberg-Henriksson HK. Hyperglycemia activates glucose transport in rat skeletal muscle via a Ca (2+)-dependent mechanism. Diabetes 44: 1345-1348, 1995.
36. Polsky S, Howard AA, Bray GA, Brown-Friday J, Perreault L, Whittington T, Barrett-Connor E, Foo S, Ma Y, Edelstein S, Crandall J. Moderate alcohol consumption is associated with lower diabetes risk in the Diabetes Prevention Program (Abstract). Diabetes 57, Suppl 1: 102-OR, 2008.
37. Puhakainen I, Koivisto VA, Yki-Jarvinen H. No reduction in total hepatic glucose output by inhibition of gluconeogenesis with ethanol in T2DM patients. Diabetes 40: 1319-1327, 1991.
38. Puhakainen I, Yki-Jarvinen H. Inhibition of lipolysis decreases lipid oxidation and gluconeogenesis from lactate but not fasting hyperglycemia or total hepatic glucose production in NIDDM. Diabetes 42: 1694-1699, 1993.
39. Ramchandani VA, Bolane J, Li TK, O'Connor S. A physiologically-based pharmacokinetic (PBPK) model for alcohol facilitates rapid BrAC clamping. Alcohol Clin Exp Res 23: 617-623, 1999.
40. Rossetti L, Chen W, Hu M, Hawkins M, Barzilai N, Efrat S. Abnormal regulation of HGP by hyperglycemia in mice with a disrupted glucokinase allele. Am J Physiol Endocrinol Metab 273: E743-E750, 1997.
41. Sarkola T, Iles MR, Kohlenberg-Mueller K, Eriksson CJ. Ethanol, acetaldehyde, acetate, and lactate levels after alcohol intake in white men and women: effect of 4-methylpyrazole. Alcohol Clin Exp Res 26: 239-245, 2002.
42. Shah P, Basu A, Rizza R. Fat-induced liver insulin resistance. Curr Diab Rep 3: 214-218, 2003.
43. Song S, Andrikopoulos S, Filippis C, Thorburn AW, Khan D, Proietto J. Mechanism of fat-induced hepatic gluconeogenesis: effect of metformin. Am J Physiol Endocrinol Metab 281: E275-E282, 2001.
44. Staehr P, Hother-Nielsen O, Landau BR, Chandramouli V, Holst JJ, Beck-Nielsen H. Effects of free fatty acids per se on glucose production, gluconeogenesis, and glycogenolysis. Diabetes 52: 260-267, 2003.
45. Stingl H, Krssak M, Krebs M, Bischof MG, Nowotny P, Furnsinn C, Shulman GI, Waldhausl W, Roden M. Lipid-dependent control of hepatic glycogen stores in healthy humans. Diabetologia 44: 48-54, 2001.
46. Van Poelje PD, Potter SC, Fujitaki JM, Dang Q, Linemeyer DL, Erion MD. MB07803, a prodrug of a second generation fructose-1,6-bisphosphatase inhibitor, lowers blood glucose in diabetic rodents, and in cynomolgus monkeys (Abstract). Diabetes 57, Suppl 1: 350-OR, 2008.
47. Williamson JR, Kreisberg RA, Felts PW. Mechanism for the stimulation of gluconeogenesis by fatty acids in perfused rat liver. Proc Natl Acad Sci USA 56: 247-254, 1966.
48. Wolfe RR, Shaw JH, Jahoor F, Herndon DN, Wolfe MH. Response to glucose infusion in humans: role of changes in insulin concentration. Am J Physiol Endocrinol Metab 250: E306-E311, 1986.
49. Zhou YP, Grill VE. Long-term exposure of rat pancreatic islets to fatty acids inhibits glucose-induced insulin secretion and biosynthesis through a glucose fatty acid cycle. J Clin Invest 93: 870-876, 1994.
50. Zierath JR, Housenecht KL, Gnudi L, Kahn BB. High-fat feeding impairs insulin-stimulated GLUT4 recruitment via an early insulin-signaling defect. Diabetes 46: 215-223, 1997.